Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation analysis of the BCCIP gene for breast cancer susceptibility in breast/ovarian cancer families.

Gynecologic oncology - 1 Nov 2013

Bonache Sandra, Gutierrez-Enriquez Sara, Tenés Anna, Masas Miriam, Balmaña Judith, Diez Orland

Abstract excerpt

OBJECTIVE: About 5%-10% of breast cancer is due to inherited disease predisposition. Currently, mutations in the BRCA1 and BRCA2 genes explain less than 25% of the familial clustering of breast cancer, and additional susceptibility genes are suspected. The BCCIP gene plays an important role in the regulation of gene transcription and cell proliferation and could be involved in the maintenance of genomic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms, Male

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Calcium-Binding Proteins

Share to Family Health

Share to Germ-Line Mutation

Share to Introns

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 23911796
DOI: 10.1016/j.ygyno.2013.07.104

Genes

BCCIP
BRCA2
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation analysis of the BCCIP gene for breast cancer susceptibility in breast/ovarian cancer families.PMID 23911796Read ↗

Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.Semantic proximity Read ↗

Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study.Semantic proximity Read ↗

The RAD51C exonic splice-site mutations c.404G>C and c.404G>T are associated with familial breast and ovarian cancer.Semantic proximity Read ↗

BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.Semantic proximity Read ↗

A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer.Semantic proximity Read ↗

BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.Semantic proximity Read ↗

Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.Semantic proximity Read ↗

Identification of a novel pathogenic mutation in BRCA2 in a Spanish breast-ovarian cancer family.Semantic proximity Read ↗

Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy.Semantic proximity Read ↗

Identification of a novel in-frame deletion in BRCA2 and analysis of variants of BRCA1/2 in Italian patients affected with hereditary breast and ovarian cancer.Semantic proximity Read ↗

BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin.Semantic proximity Read ↗

Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.